← Back to results

Posted · FOR-FD-20-010

Drug Development Science Support (U01)

Food and Drug Administration  ·  HHS

CFDA Numbers

93.103

Award Ceiling

Award Floor

Expected Awards

5

Close Date

Section I

How to Apply

View on grants_gov ↗

Program Contact

Shashi Malhotra <br/>Grants Management Specialist
shashi.malhotra@fda.hhs.gov

Section II

Eligibility

Higher Education Institutions- Public/State Controlled Institutions of Higher Education - Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: - Hispanic-serving Institutions- Historically Black Colleges and Universities (HBCUs)- Tribally Controlled Colleges and Universities (TCCUs) - Alaska Native and Native Hawaiian Serving Institutions- Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)Nonprofits Other Than Institutions of Higher Education- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) - Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations- Small Businesses- For-Profit Organizations (Other than Small Businesses)Governments- State Governments - County Governments- City or Township Governments- Special District Governments- Indian/Native American Tribal Governments (Federally Recognized) - Indian/Native American Tribal Governments (Other than Federally Recognized)Eligible Agencies of the Federal Government- U.S. Territory or PossessionOther- Independent School Districts- Public Housing Authorities/Indian Housing Authorities- Native American Tribal Organizations (other than Federally recognized tribal governments)- Faith-based or Community-based Organizations- Regional Organizations

Eligible Applicant Types

00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25

Section III

Description

The Food and Drug Administration (FDA) Office of the Chief Scientist (OCS) and FDA Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) will annouce it's intent to accept and consider an application for the award of a grant to protect and promote the health of the American public by creating new, applied scientific knowledge, tools, standards and approaches to evaluate products more effectively, predictably and efficiently.

Section IV

Key Dates

Posted
May 25, 2021
Archive
May 26, 2021